Paediatric community-acquired pneumonia: current concept in pharmacological control

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2003-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14656566.4.5.761PMID 12739999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology, Control and Treatment of Multiresistant Pneumococci

  2012cited by this paper
• Aetiology of community-acquired pneumonia in children treated in hospital

  2005cited by this paper
• Serum procalcitonin concentrations in bacterial pneumonia in children: A negative result in primary healthcare settings

  2003cited by this paper
• Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.

  2003cited by this paper
• Opportunistic screening for genital chlamydial infection. II: Prevalence among healthcare attenders, outcome, and evaluation of positive cases

  2003cited by this paper
• Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain.

  2003cited by this paper
• Effect of treatment for Chlamydia trachomatis during pregnancy

  2003cited by this paper
• Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy.

  2003cited by this paper
• Differentiation of bacterial and viral pneumonia in children

  2002cited by this paper
• Physician perspectives regarding pneumococcal conjugate vaccine.

  2002cited by this paper
• Rapid antigen assay for the diagnosis of pneumococcal bacteremia in children: a preliminary study.

  2002cited by this paper
• Emerging resistance to antibiotics against respiratory bacteria: impact on therapy of community-acquired pneumonia in children.

  2002cited by this paper
• Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia.

  2002cited by this paper
• Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity

  2002cited by this paper
• Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants.

  2002cited by this paper
• Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection.

  2002cited by this paper
• Pertussis of adults and infants.

  2002cited by this paper
• Influenza-related hospitalizations among children in Hong Kong.

  2002cited by this paper
• Community-acquired pneumonia in children.

  2002cited by this paper
• Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection.

  2002cited by this paper
• From the Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children-- United States, 1998-2000.

  2002cited by this paper
• Progress toward elimination of Haemophilus influenzae type b invasive disease among infants and children--United States, 1998-2000.

  2002cited by this paper
• Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods.

  2002cited by this paper
• Recurrent pneumonia in children: clinical profile and underlying causes

  2002cited by this paper
• The UK Hib vaccine experience

  2002cited by this paper
• Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia.

  2002cited by this paper
• Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine

  2002cited by this paper
• Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

  2002cited by this paper
• Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families.

  2002cited by this paper
• Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine

  2002cited by this paper
• Influence of infection with Chlamydia trachomatis on pregnancy outcome, infant health and life-long sequelae in infected offspring.

  2002cited by this paper
• Chronic and recurrent pneumonias in children.

  2002influential reference
• Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

  2002cited by this paper
• Management of community-acquired pediatric pneumonia in an era of increasing antibiotic resistance and conjugate vaccines

  2002influential reference
• The potential of pneumococcal conjugate vaccines for children

  2002cited by this paper
• Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae.

  2002cited by this paper
• Community-acquired pneumonia: new guidelines for management.

  2001cited by this paper
• American Academy of Pediatrics: Tobacco's toll: implications for the pediatrician.

  2001cited by this paper
• Clinical profile of serologically diagnosed pneumococcal pneumonia.

  2001cited by this paper
• Community-acquired pneumonia: the evolving challenge.

  2001cited by this paper
• Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections.

  2001cited by this paper
• Tobacco's Toll: Implications for the Pediatrician

  2001cited by this paper
• Reappraisal of lung tap: review of an old method for better etiologic diagnosis of childhood pneumonia.

  2001cited by this paper
• Procalcitonin in children admitted to hospital with community acquired pneumonia

  2001cited by this paper
• Long-Term Pertussis-Specific Immunity after Primary Vaccination with a Combined Diphtheria, Tetanus, Tricomponent Acellular Pertussis, and Hepatitis B Vaccine in Comparison with That after Natural Infection

  2001cited by this paper
• Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections.

  2001influential reference
• The clinical impact of macrolide resistance in pneumococcal respiratory infections.

  2001influential reference
• STREPTOCOCCUS PNEUMONIAE IN COMMUNITY-AQUIRED PNEUMONIA

  2001cited by this paper
• Association of Amino Acid Substitutions in Penicillin-Binding Protein 3 with β-Lactam Resistance in β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae

  2001cited by this paper
• Prevalence of Antimicrobial Resistance in Streptococcus pneumoniae Circulating in Italy: Results of the Italian Epidemiological Observatory Survey (1997-1999)

  2001cited by this paper
• Macrolide resistance among invasive Streptococcus pneumoniae isolates.

  2001cited by this paper
• Epidemiological aspects of antibiotic resistance in respiratory pathogens

  2001cited by this paper
• Community-acquired pneumonia: new guidelines for management

  2001cited by this paper
• The Japanese experience with vaccinating schoolchildren against influenza.

  2001cited by this paper
• Streptococcus pneumoniae in community-acquired pneumonia. How important is drug resistance?

  2001cited by this paper
• Serum procalcitonin in pneumococcal pneumonia in children.

  2001cited by this paper
• Evaluation of Binax NOW, an assay for the detection of pneumococcal antigen in urine samples, performed among pediatric patients.

  2001cited by this paper
• Respiratory Viral Infections among Pediatric Inpatients and Outpatients in Taiwan from 1997 to 1999

  2001cited by this paper
• Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Mowgli Study Group.

  2001cited by this paper
• The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.

  2000cited by this paper
• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults

  2000cited by this paper
• Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection.

  2000cited by this paper
• Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts.

  2000cited by this paper
• The burden of influenza illness in children with asthma and other chronic medical conditions.

  2000cited by this paper
• Streptococcus pneumoniae andMycoplasma pneumoniae coinfection in community acquired pneumonia

  2000cited by this paper
• The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project.

  2000cited by this paper
• Influenza and the rates of hospitalization for respiratory disease among infants and young children.

  2000cited by this paper
• Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.

  2000cited by this paper
• Antimicrobial Resistance in Respiratory Tract Pathogens: Results of an International Surveillance Study

  2000cited by this paper
• Etiology of community‐acquired pneumonia in 254 hospitalized children

  2000influential reference
• Underlying causes of recurrent pneumonia in children.

  2000cited by this paper
• The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

  2000cited by this paper
• Etiology and treatment of pneumonia

  2000influential reference
• Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group.

  1999cited by this paper
• Perinatally acquired Chlamydia trachomatis associated morbidity in young infants.

  1999cited by this paper
• Comparative Tolerability of Erythromycin and Newer Macrolide Antibacterials in Paediatric Patients

  1999cited by this paper
• Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 Oral Antimicrobial Agents Based on Pharmacodynamic Parameters: 1997 U.S. Surveillance Study

  1999cited by this paper
• Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy.

  1999cited by this paper
• Childhood community-acquired pneumonia.

  1999cited by this paper
• Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997 98.

  1999cited by this paper
• High rates of Chlamydia trachomatis infections in young Papua New Guinean infants.

  1999cited by this paper
• Etiology and treatment of community-acquired pneumonia in ambulatory children.

  1999cited by this paper
• Efficacy of High-Dose Amoxicillin-Clavulanate against Experimental Respiratory Tract Infections Caused by Strains ofStreptococcus pneumoniae

  1999cited by this paper
• Magnitude of the problem of childhood pneumonia.

  1999cited by this paper
• Extremely High Incidence of Macrolide and Trimethoprim-Sulfamethoxazole Resistance among Clinical Isolates ofStreptococcus pneumoniae in Taiwan

  1999cited by this paper
• Risk Factors and Course of Illness Among Children With Invasive Penicillin-resistant Streptococcus pneumoniae

  1999cited by this paper
• Progress toward eliminating Haemophilus influenzae type b disease among infants and children--United States, 1987-1997.

  1999cited by this paper
• Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.

  1998cited by this paper
• Etiology of childhood pneumonia: serologic results of a prospective, population-based study.

  1998influential reference
• Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.

  1998cited by this paper
• The burden of environmental tobacco smoke exposure on the respiratory health of children 2 months through 5 years of age in the United States: Third National Health and Nutrition Examination Survey, 1988 to 1994.

  1998cited by this paper
• Community-acquired pneumonia

  1998cited by this paper
• Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.

  1998cited by this paper
• Community-acquired pneumonia

  1998cited by this paper
• Causes of childhood deaths in Bangladesh: results of a nationwide verbal autopsy study.

  1998cited by this paper
• Therapy for children with invasive pneumococcal infections

  1997cited by this paper
• White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children.

  1997cited by this paper
• Therapy for children with invasive pneumococcal infections. American Academy of Pediatrics Committee on Infectious Diseases.

  1997cited by this paper
• Molecular basis of antimicrobial resistance in non-typable Haemophilus influenzae.

  1997cited by this paper
• Acellular pertussis vaccine: recommendations for use as the initial series in infants and children. American Academy of Pediatrics Committee on Infectious Diseases.

  1997cited by this paper

• Salivary C-reactive protein—a possible predictor of serum levels in pediatric acute respiratory illness

  2021cites this paper
• Insights into antibiotic use in children with CAP

  2017cites this paper
• Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.

  2015cites this paper
• Performance of lung ultrasonography in children with community-acquired pneumonia

  2014cites this paper
• Do We Know When, What and For How Long to Treat?: Antibiotic Therapy for Pediatric Community-acquired Pneumonia

  2012cites this paper
• Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia.

  2011cites this paper
• Legionellosis must be kept in mind in case of pneumonia with lung abscesses in children receiving therapeutic steroids

  2011cites this paper
• Management of severe community-acquired pneumonia of children in developing and developed countries

  2010cites this paper
• Pharmacotherapy of childhood pneumonia

  2010cites this paper
• Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age

  2007cites this paper
• Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein

  2005influential citation
• Neumonía adquirida en la comunidad en lactantes y preescolares del municipio de Turbo, Antioquia

  2004cites this paper
• Management of severe community-acquired pneumonia of children in developing and developed countries

  year unknowninfluential citation
• Management of severe community-acquired pneumonia of children in developing and developed countries

  year unknowninfluential citation
• Management of severe community-acquired pneumonia of children in developing and developed countries

  year unknowninfluential citation
• THORAXJNL142604 815..822

  year unknowninfluential citation
• Management of severe community-acquired pneumonia of children in developing and developed countries

  year unknowninfluential citation